查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲基因检测服务市场预测至 2030 年 - 区域分析 - 按服务类型、疾病和服务提供者
市场调查报告书
商品编码
1533074

欧洲基因检测服务市场预测至 2030 年 - 区域分析 - 按服务类型、疾病和服务提供者

Europe Genetic Testing Services Market Forecast to 2030 - Regional Analysis - by Service Type, Disease, and Service Provider
出版日期: | 出版商: The Insight Partners | 英文 108 Pages | 订单完成后即时交付

价格

2022年欧洲基因检测服务市值9.3111亿美元，预计2030年将达27.7842亿美元；预计2022年至2030年复合年增长率为14.6%。

对个人化药物的认识和接受度不断提高推动欧洲基因检测服务市场

个人化医疗是利用患者的遗传和环境资料提供最佳医疗保健的领域。它基于每个患者都是独特的并且需要个别化药物治疗的原则。由于它是一个快速发展的领域，目前已纳入多个医疗保健系统。 2003年人类基因组计画（HGP）的成功完成以及人类基因组定序成本的快速下降鼓励了一种新的医疗方法的发展，即个人化医疗。随着分子层级个人化资料储存库的不断扩大，分子诊断公司在释放价值方面处于特殊地位。大规模药物发现是提高个人化药物在疾病和病症诊断的可行性和有用性的关键。基因组学是医学科学中发展最快的部门之一。它正在推动疾病研究方法以及疾病诊断和治疗的范式转移。基因检测已广泛应用于药物基因组学，也称为药物基因检测。它有助于加速药物发现及其开发。法国也制定了一项名为「法国基因组医学 2025」的个人化医疗国家计画。 2016 年6 月，阿维桑国家生命与健康科学联盟主席兼Inserm 首席执行官伊夫·利维(Yves Levy) 向总理曼努埃尔·瓦尔斯(Manuel Valls) 提交了该计划。保健和製造公司试点基因组定序平台。该计划得到了政府的支持，并于 2020 年启动了 7.608 亿美元（6.7 亿欧元）的公共融资，用于基因组学和个性化医疗项目。预计未来十年内法国将成为基因组医学领域的领先国家。 2023 年 1 月，人类基因组计画将开启个人化医疗保健时代。现在，新的研究表明，使用基因检测进行精确处方最终已达到全球采用的临界点。这项经过同行评审的研究由剑桥大学出版社出版，研究了大规模使用临床遗传学所需的关键因素的成熟度。这些进步为支持将基于基因组的临床决策建立为新的护理标准铺平了道路。基因知情处方提供了成功降低医疗保健系统总体成本和改善个别患者护理的现实机制之一。基因检测透过了解疾病背后的科学、治疗的影响以及针对特定个体特征的疗法的开发，鼓励采用个人化医疗方法。它还可以帮助医护人员利用基因检测结果做出有关疾病诊断、治疗和预防的明智决策，从而改善患者的治疗结果。

欧洲基因检测服务市场概况

欧洲基因检测服务市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。基因检测一直以惊人的速度成长。现在提供大量测试来筛检多种遗传疾病。许多罕见遗传疾病都有治疗方法，而且这个过程在携带者检测、新生儿筛检、预测性和症状前检测等场景中变得越来越重要。此外，欧洲国家也采取了一系列措施来提高人们对基因检测益处的认识。最终目标是确保基因检测的各个方面都是高品质的，从而提供准确可靠的结果，造福患者。

欧洲基因检测服务市场收入及 2030 年预测（百万美元）

欧洲基因检测服务市场细分

欧洲基因检测服务市场按服务类型、疾病、服务提供者和国家分类。

根据服务类型，欧洲基因检测服务市场可细分为预测检测、带因者检测、产前检测、新生儿筛检等。预测测试领域在 2022 年占据最大的市场份额。

从疾病类型来看，欧洲基因检测服务市场分为癌症、代谢疾病、心血管疾病和其他疾病。 2022 年，癌症细分市场占据最大的市场。

依服务提供者划分，欧洲基因检测服务市场分为医院实验室、诊断实验室等。 2022 年，医院实验室细分市场占据最大市场份额。

依国家/地区划分，欧洲基因检测服务市场分为英国、德国、法国、西班牙、义大利和欧洲其他地区。 2022年，德国在欧洲基因检测服务市场份额中占据主导地位。

Eurofins Scientific SE、Exact Sciences Corp、Laboratory Corp of America Holdings、23andMe Holding Co、Quest Diagnostics Inc、Illumina Inc、F. Hoffmann-La Roche Ltd、NeoGenomics Inc 和 Centogene AG 是欧洲基因检测领域的领先公司之一服务市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲基因检测服务市场 - 主要产业动态

  • 主要市场驱动因素
    • 遗传性疾病盛行率上升
    • 提高对个人化药物的认识和接受度
    • 对直接面向消费者 (DTC) 的基因检测的偏好日益增长
  • 市场限制
    • 基因检测的社会和伦理影响
    • 遗传服务的承受能力
  • 市场机会
    • 对药物基因组学的需求不断增长
  • 未来趋势
    • 人工智慧驱动的基因检测
  • 影响分析：

第 5 章：基因检测服务市场 - 欧洲市场分析

  • 欧洲基因检测服务市场收入，2022 - 2030

第 6 章：欧洲基因检测服务市场 - 收入和 2030 年预测 - 按服务类型

  • 概述
  • 2022 年及 2030 年欧洲基因检测服务市场收入份额，依服务类型划分 (%)
  • 预测测试
  • 运营商测试
  • 产前检测
  • 新生儿筛检
  • 其他的

第 7 章：欧洲基因检测服务市场 - 收入和 2030 年预测 - 按疾病分类

  • 概述
  • 2022 年及 2030 年欧洲基因检测服务市场收入份额（按疾病划分）（%）
  • 癌症
  • 心血管疾病
  • 代谢性疾病
  • 其他疾病

第 8 章：欧洲基因检测服务市场 - 收入和 2030 年预测 - 按服务提供者

  • 概述
  • 2022 年和 2030 年欧洲基因检测服务市场收入份额（按服务提供者划分）（%）
  • 医院实验室
  • 诊断实验室
  • 其他的

第 9 章：欧洲基因检测服务市场 - 国家分析

  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 10 章：基因检测服务市场-产业格局

  • 概述
  • 基因检测服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 11 章：公司简介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • 23andMe Holding Co
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene AG

第 12 章：附录

Product Code: TIPRE00009240

The Europe genetic testing services market was valued at US$ 931.11 million in 2022 and is expected to reach US$ 2,778.42 million by 2030; it is estimated to register a CAGR of 14.6% from 2022 to 2030.

Increasing Awareness and Acceptance of Personalized Medicines Drive Europe Genetic Testing Services Market

Personalized medicine is the field that utilizes patients' genetic and environmental data to deliver optimal healthcare. It is based on the principle that every patient is unique and requires individualistic pharmacological treatment. Since it is a rapidly evolving area, it is presently incorporated into several healthcare systems. The successful completion of the Human Genome Project (HGP) in 2003 and the fast-decreasing human genome sequencing costs encouraged the development of a new medical approach, which is called personalized medicine. With an expanding repository of personalized data at the molecular level, molecular diagnostics companies are exceptionally positioned to unlock value. Large-scale drug discovery is a key to increasing the viability and usefulness of personalized medicines for the diagnosis of diseases and disorders. Genomics is one of the fastest-growing divisions of medical science. It is driving a paradigm shift in the research methodology of a disease, as well as diagnosing and treating illness. Genetic testing has been extensively used in pharmacogenomics, also known as drug-gene testing. It helps in accelerating drug discovery and its development. France also developed a national plan for personalized medicine known as "Genomic Medicine France 2025." The program was presented to Prime Minister Manuel Valls by Yves Levy, President of the National Alliance for Life and Health Sciences-Aviesan and CEO of Inserm, in June 2016. It appeals to healthcare and manufacturing firms to pilot genomic sequencing platforms. The plan was supported by the government and launched with a public financing of US$ 760.8 million (€670 million) in 2020 for genomics and personalized medicine programs. It is expected to place France as a leader among countries involved in genomic medicine within the next ten years. In January 2023, The Human Genome Project is ensuring an era of personalized healthcare. Now, new research shows that precision prescribing using genetic testing has ultimately reached a global tipping point for adoption. Published by Cambridge University Press, the peer-reviewed research examines the maturation of critical factors required for the use of clinical genetics at scale. These advancements pave the way for supporting genome-informed clinical decision-making to be established as the new standard of care. Genetically informed prescribing offers one of the realistic mechanisms to successfully reduce the overall costs of the healthcare system and improve individual patient care. Genetic testing encourages the adoption of a personalized medicine approach by understanding the science behind the disease, the impact of treatment, and the development of therapies for specific individual characteristics. It also helps healthcare personnel make informed decisions about disease diagnosis, treatment, and prevention by utilizing genetic testing results, leading to improved patient outcomes.

Europe Genetic Testing Services Market Overview

European genetic testing services market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Genetic testing has been growing at an exceptional rate; a large panel of tests are now offered to screen a number of genetic diseases. Treatments are available for a number of rare genetic diseases, and the process is gaining importance in scenarios such as carrier testing, newborn screening, and predictive and pre-symptomatic testing, among others. Moreover, European countries have undertaken a number of initiatives to increase awareness among people about the benefits of genetic testing. The ultimate goal is to ensure that all aspects of genetic testing are of high quality, thereby providing accurate and reliable results for the benefit of the patients.

Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Europe Genetic Testing Services Market Segmentation

The Europe genetic testing services market is categorized into service type, disease, service provider, and country.

Based on service type, the Europe genetic testing services market is segmented predictive testing, carrier testing, prenatal testing, newborn screening, and others. The predictive testing segment held the largest market share in 2022.

In terms of disease, the Europe genetic testing services market is categorized into cancer, metabolic diseases, cardiovascular diseases, and other diseases. The cancer segment held the largest market share in 2022.

By service provider, the Europe genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. The hospital-based laboratories segment held the largest market share in 2022.

By country, the Europe genetic testing services market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe genetic testing services market share in 2022.

Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, and Centogene AG are among the leading companies operating in the Europe genetic testing services market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Genetic Testing Services Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Prevalence of Genetic Diseases
    • 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 4.2 Market Restraints
    • 4.2.1 Social and Ethical Implications of Genetic Testing
    • 4.2.2 Affordability of Genetic Services
  • 4.3 Market Opportunities
    • 4.3.1 Rising Demand for Pharmacogenomics
  • 4.4 Future Trends
    • 4.4.1 Artificial Intelligence-Powered Genetic Testing
  • 4.5 Impact Analysis:

5. Genetic Testing Services Market - Europe Market Analysis

  • 5.1 Europe Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030

6. Europe Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Type

  • 6.1 Overview
  • 6.2 Europe Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • 6.3 Predictive Testing
    • 6.3.1 Overview
    • 6.3.2 Predictive Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Carrier Testing
    • 6.4.1 Overview
    • 6.4.2 Carrier Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Prenatal Testing
    • 6.5.1 Overview
    • 6.5.2 Prenatal Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Newborn Screening
    • 6.6.1 Overview
    • 6.6.2 Newborn Screening: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Genetic Testing Services Market - Revenue and Forecast to 2030 - by Disease

  • 7.1 Overview
  • 7.2 Europe Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • 7.3 Cancer
    • 7.3.1 Overview
    • 7.3.2 Cancer: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Cardiovascular Diseases
    • 7.4.1 Overview
    • 7.4.2 Cardiovascular Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Metabolic Diseases
    • 7.5.1 Overview
    • 7.5.2 Metabolic Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Other Diseases
    • 7.6.1 Overview
    • 7.6.2 Other Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Provider

  • 8.1 Overview
  • 8.2 Europe Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • 8.3 Hospital-Based Laboratories
    • 8.3.1 Overview
    • 8.3.2 Hospital-Based Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Diagnostic Laboratories
    • 8.4.1 Overview
    • 8.4.2 Diagnostic Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Genetic Testing Services Market - Country Analysis

  • 9.1 Europe
    • 9.1.1 Europe Genetic Testing Services Market, by Country
      • 9.1.1.1 UK
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.1.3 UK Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.1.4 UK Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.1.5 UK Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.2 Germany
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Germany: Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 Germany: Europe Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.2.4 Germany: Europe Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.2.5 Germany: Europe Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.3 France
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 France Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.3.4 France Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.3.5 France Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.4 Italy
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 Italy Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.4.4 Italy Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.4.5 Italy Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.5 Spain
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.3 Spain Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.5.4 Spain Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.5.5 Spain Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.6 Rest of Europe
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.6.3 Rest of Europe Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.6.4 Rest of Europe Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.6.5 Rest of Europe Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)

10. Genetic Testing Services Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Genetic Testing Services Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Eurofins Scientific SE
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Exact Sciences Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Laboratory Corp of America Holdings
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 23andMe Holding Co
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Quest Diagnostics Inc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Illumina Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 F. Hoffmann-La Roche Ltd
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 NeoGenomics Inc
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Centogene AG
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Genetic Testing Services Market Segmentation
  • Table 2. UK Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. UK Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany: Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany: Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Germany: Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Italy Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Italy Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Italy Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Spain Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Spain Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Spain Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 21. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 22. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Europe Genetic Testing Services Market Segmentation, By Country
  • Figure 2. Europe Genetic Testing Services Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • Figure 6. Predictive Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Carrier Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Prenatal Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Newborn Screening: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Europe Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • Figure 12. Cancer: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cardiovascular Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Metabolic Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Other Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • Figure 17. Hospital-Based Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Diagnostic Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 21. Europe Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Germany: Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Growth Strategies in Genetic Testing Services Market